Mutagenic activity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

• Autorzy: Ulanowska K , Wegrzyn G
• Języki publikacji: EN

Abstrakty

EN

MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) is a neurotoxin, which can damage dopaminergic neurons. It causes symptoms resembling those observed in patients suffering from Parkinson’s disease, and hence this toxin is widely used in studies on animal models of this disorder. Mutagenicity of MPTP was also reported by some authors, but results obtained by others suggested that this compound is not mutagenic. Interestingly, those contrasting results were based on the same assay (the Ames test). Therefore, we aimed to test MPTP mutagenicity by employing a recently developed Vibrio harveyi assay, which was demonstrated previously to be more sensitive than the Ames test, at least for some mutagens. We found that MPTP showed a significant mutagenic activity. Moreover, MPTP mutagenicity was attenuated by methylxanthines, compounds that are known to form complexes with aromatic mutagens.

Słowa kluczowe

EN

human disease; neurotoxin; 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; dopaminergic neuron; mutagen; mutagenicity; Vibrio harveyi; mutagenic activity; Parkinson's disease

• Wydawca: -
• Czasopismo: Journal of Applied Genetics
• Rocznik: 2006
• Tom: 47
• Numer: 1
• Opis fizyczny: p.85-87,ref.

Twórcy

autor

Ulanowska K

• Department of Molecular Biology, University of Gdansk, Kladki 24, 80-822 Gdansk, Poland

autor

Wegrzyn G

• Department of Molecular Biology, University of Gdansk, Kladki 24, 80-822 Gdansk, Poland
• Department of Genetic and Marine Biotechnology, Institute of Oceanology, Polish Academy of Sciences, Gdynia, Poland

Bibliografia

• Cashman JR, 1987. Mutagenicity of MPTP (1 -methyl-4-phenyl-1,2,3,6-tetrahydropyridine) and its metabolites. Toxicology 43: 173-182.
• Czyż A, Jasiecki J, Bogdan A, Szpilewska H, Węgrzyn G, 2000. Genetically modified Vibrio harveyi strains as potential bioindicators of mutagenic pollution of marine environments. Appl Environ Microbiol 66: 599-605.
• Czyż A, Szpilewska H, Dutkiewicz R, Kowalska W, Biniewska-Godlewska A, Węgrzyn G, 2002. Comparison of the Ames test and a newly developed assay for detection of mutagenic pollution of marine environments. Mutat Res 519: 67-74.
• Czyż A, Kowalska W, Węgrzyn G, 2003. Vibrio harveyi mutagenicity assay as a preliminary test for detection of mutagenic pollution of marine water. Bull Environ Contamin Toxicol 70: 1065-1070.
• Klein G, Walczak R, Krasnowska E, Błaszczak A, Lipińska B, 1995. Characterization of heat-shock response of the marine bacterium Vibrio harveyi. Mol Microbiol 16: 801-811.
• Maron DM, Ames BN, 1983. Revised methods for the Salmonella mutagenicity test. Mutat Res 113: 173-215.
• Mortelmans K, Zeiger E, 2000. The Ames Salmonella/microsome mutagenicity assay. Mutat Res 455: 29-60.
• Piosik J, Ulanowska K, Gwizdek-Wiśniewska A, Czyż A, Kapuściński J, Węgrzyn G, 2003. Alleviation of mutagenic effects of polycyclic aromatic agents (quinacrine mustard, ICR-191 and ICR-170) by caffeine and pentoxifylline. Mutat Res 530: 47-57.
• Piosik J, Gwizdek-Wiśniewska A, Ulanowska K, Sochociński J, Czyż A, Węgrzyn G, 2005. Methylxanthines (caffeine, pentoxifylline and theophylline) decrease the mutagenic effect of daunomycin, doxorubicin and mitoxantrone. Acta Biochim Pol, in press.
• Podgórska B, Chęć E, Ulanowska K, Węgrzyn G, 2005. Optimisation of the microbiological mutagenicity assay based on genetically modified Vibrio harveyi strains. J Appl Gen 46: 241-246.
• Singer TP, Ramsay RR, 1990. Mechanism of the neurotoxicity of MPTP. An update. FEBS Lett 274: 1-8.
• Speciale SG, 2002. MPTP. Insights into parkinsonian neurodegeneration. Neurotoxicol Teratol 24: 607-620.
• Węgrzyn G, Czyż A, 2003. Detection of mutagenic pollution of natural environment using microbiological assays. J Appl Microbiol 95: 1175-1181.
• Yang SC, Markey SP, Bartkiewicz KS, London WT, Lunn G, 1988. Recommended safe practices for using the neurotoxin MPTP in animal experiments. Lab Anim Sci 38: 563-567.